바이
바이오솔루션 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 장송선, was filed 08 Mar 2023.
바이오솔루션: what insiders have been doing
We have very little insider data for 바이오솔루션 so far: the most recent filing dates from 12 March 2026. With so few records, no pattern can be drawn yet. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€33,069
1 ops. · all time
Sell Volume
n/a
n/a
Fundamental score
Ranked 20,574 of 26,912 companies
33.3
score / 100
Value24
Quality42
FCF yld-1.4%
Earn yld0.2%
EV/EBITDA34.1x
ROE2.5%
Gross mgn63%
Net mgn1.8%
Debt/EBITDA5.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
₩5,790
Analyst consensus
Income statement
Revenue₩15.2B
Gross profit₩9.6B63% margin
EBITDA₩5.3B35% margin
Net income₩273.4M5.0% margin
Valuation
PER (forward)42.9x
Beta-0.17
Balance sheet & cash
Market cap₩149.4B
Total debt₩30B
Free Cash Flow-₩2B
Debt / Equity46%
Profitability & ownership
ROE2.5%
ROA-3.3%
% insiders17.6%
% institutions0.1%
Last declaration on 12 March 2026
Declarations11 total
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 11,713 sharesKRXDART:20230308000202Canonical exit: 6 Jun 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
11 of 11 declarations
About 바이오솔루션
BioSolution is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative biological solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
